Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease
Public ClinicalTrials.gov record NCT01584440. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.
Study identification
- NCT ID
- NCT01584440
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Avanir Pharmaceuticals
- Industry
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Interventions
- AVP-923-20 Drug
- Placebo Drug
- AVP-923-30 Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 12, 2012
- Primary completion
- Jul 29, 2014
- Completion
- Jul 29, 2014
- Last update posted
- Nov 25, 2021
2012 – 2014
United States locations
- U.S. sites
- 44
- U.S. states
- 14
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85006 | — |
| Not listed | Sun City | Arizona | 85351 | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | Fullerton | California | 92835 | — |
| Not listed | Los Angeles | California | 90073 | — |
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Francisco | California | 94109 | — |
| Not listed | Sherman Oaks | California | 91403 | — |
| Not listed | Temecula | California | 92591 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | Deerfield Beach | Florida | 33064 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Miami | Florida | 33122 | — |
| Not listed | Miami | Florida | 33137 | — |
| Not listed | Miami | Florida | 33173 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Sunrise | Florida | 33351 | — |
| Not listed | Tampa | Florida | 33609 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | Weston | Florida | 33331 | — |
| Not listed | Elk Grove Village | Illinois | 60007 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Las Vegas | Nevada | 89147 | — |
| Not listed | Summit | New Jersey | 07902 | — |
| Not listed | Toms River | New Jersey | 08757 | — |
| Not listed | Orangeburg | New York | 10962 | — |
| Not listed | Rochester | New York | 14620 | — |
| Not listed | White Plains | New York | 10605 | — |
| Not listed | Centerville | Ohio | 45459 | — |
| Not listed | Cincinnati | Ohio | 45227 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Columbus | Ohio | 43221 | — |
| Not listed | Lakewood | Ohio | 44107 | — |
| Not listed | Allentown | Pennsylvania | 18104 | — |
| Not listed | Reading | Pennsylvania | 19604 | — |
| Not listed | Charleston | South Carolina | 29401 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78238 | — |
| Not listed | Salt Lake City | Utah | 84106 | — |
| Not listed | Bennington | Vermont | 05201 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01584440, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 25, 2021 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01584440 live on ClinicalTrials.gov.